Health and Wellness

Weight loss drug development is booming in China. Here’s why

China, known for having one of the lowest rates of obesity in the developed world, has surprisingly emerged as one of the top locations for testing new weight loss drugs.

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

New ACIP charter: Broader membership, focus on vaccine injuries

Following a legal setback, health officials from the Trump administration have amended the governing documents of a crucial federal vaccine

Iran war public health, C-section rates: Morning Rounds

Stay informed on health and medicine with STAT’s free newsletter, Morning Rounds. Sign up here. An essay today in First Opinion

The U.S. metros that spend the most on health care

Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. At first glance, Charleston, W.Va.,

To get people to lower blood pressure, study suggests team approach

High blood pressure is a major contributor to heart attacks and strokes, making it a leading risk factor for mortality

Genetic changes appear to help predict response to GLP-1 drugs for weight loss

Alterations in two specific genes may help forecast whether patients will experience significant weight loss when using GLP-1 drugs for

Aerobic exercise, OTC abortion meds, insulin: Morning Rounds

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning.

Judge refuses to block sending abortion pill by mail for now

A federal judge on Tuesday declined to halt the mailing of mifepristone prescriptions across the United States, dealing a blow

Study finds missed opportunities for targeted cancer treatments

Angus Chen covers all issues broadly related to cancer, including drugs, policy, science, and equity. He joined STAT in 2021